Brief: Labcorp Launches First FDA-Cleared Blood Test For Alzheimer's Disease Assessment In Primary Care
11/02/2026 12:13
Feb 11 (Reuters) - Labcorp Holdings Inc LH.N: LABCORP LAUNCHES FIRST FDA-CLEARED BLOOD TEST FOR ALZHEIMER'S DISEASE ASSESSMENT IN PRIMARY CARE Source text: ID:nPnbP9Fr1a Further company coverage: LH.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Labcorp Holdings
See all newsBrief: Labcorp And Epic Expand Collaboration To Advance Diagnostic Integration Across Hospitals And Health Systems
U.S. STOCKS ON THE MOVE-Quanta, O'Reilly Automotive, Avis
Labcorp lifts full‑year forecast as diagnostics business stays resilient (updated)
U.S. STOCKS ON THE MOVE-Qualcomm, Meta, Cardinal Health
U.S. STOCKS ON THE MOVE-Royal Caribbean, Labcorp, Textron